Abcepta

Abcepta is a long-established, private provider of research-grade antibodies and custom biologics services, operating from San Diego. The company's core business is the development, production, and sale of antibodies, peptides, and related reagents to academic and industrial researchers worldwide. It differentiates itself through a strong emphasis on quality control, epitope-specific antibody development (including for post-translational modifications), and a comprehensive custom services division. While primarily a reagent supplier, its tools and services directly support early-stage drug discovery and target validation for its clients.

Integrated platform for traditional polyclonal and monoclonal antibody development, with emphasis on rigorous immunogen design (including for post-translational modifications), peptide synthesis, and multi-application validation. Features a premium 'Crown Antibodies' line with extended quality controls.

Abcepta competes in the global life science reagents market against giants like Thermo Fisher Scientific and Merck, as well as pure-play antibody specialists like Abcam and Cell Signaling Technology. Its differentiation is based on product quality validation, a focus on challenging epitopes, and custom service agility, rather than scale or lowest cost.